263P Clinical outcomes in patients with germline pathogenic variants in homologous recombination repair (HRR) genes treated with CDK4/6 inhibitors (CDK4/6i) and endocrine therapy (ET)

Bibliographic Details
Title: 263P Clinical outcomes in patients with germline pathogenic variants in homologous recombination repair (HRR) genes treated with CDK4/6 inhibitors (CDK4/6i) and endocrine therapy (ET)
Authors: Rodriguez Hernandez, A., Martinez Saez, O., Brasó-Maristany, F., Pastor, B., Potrony, M., Moreno, L., Grau, E., Puig-Butille, J.A., Sánchez, A., Schettini, F., Conte, B., Chic, N., Vidal Losada, M.J., Munoz, M., Balaguer, F., Prat, A., Adamo, B.
Source: In Annals of Oncology September 2022 33 Supplement 7:S657-S658
Database: ScienceDirect
More Details
ISSN:09237534
DOI:10.1016/j.annonc.2022.07.302
Published in:Annals of Oncology
Language:English